Ona Therapeutics — Series A · €10M

A €10M investment led by CDTI Innovación through its SICC Innvierte vehicle. Existing investors Asabys Partners (Sabadell Asabys Health Innovation Investments and Asabys Top Up Fund), Ysios Capital (Ysios BioFund III), Alta Life Sciences Spain I FCR and FundPlus co-invested. The announcements don't name a stage; it is filed as a Series A extension because it came between the Series A and the Series B and mostly from Series A investors. The money funds ADCs against advanced, treatment-resistant cancer.